MFS
NKTR icon

MSI Financial Services’s Nektar Therapeutics NKTR Stock Holding History

MSI Financial Services’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$12K Buy
+67
New +$13.6K ﹤0.01% 2711
2016
Q1 		– Sell
-13
Closed -$3K – 4043
2015
Q4 		$3K Buy
+13
New +$2.67K ﹤0.01% 3309

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MSI Financial Services's NKTR Position: Q4 2016 in Review

MSI Financial Services opened a new position in Nektar Therapeutics (NKTR) in Q4 2016: 67 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #2711 among its holdings. This is a return to the name: MSI Financial Services previously reported a position in NKTR as recently as Q4 2015.

MSI Financial Services first reported a position in NKTR in Q4 2015 and has held it in 2 quarters since. 199 funds tracked by Wall St. Rank hold NKTR as of Q4 2016.

  • MSI Financial Services held 67 shares of Nektar Therapeutics worth $12K as of Q4 2016.
  • Nektar Therapeutics was a new MSI Financial Services position in Q4 2016.
  • Nektar Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2711 holding.
  • MSI Financial Services first reported a position in Nektar Therapeutics in Q4 2015 and has held it in 2 quarters since.
  • 199 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.